Kimberli Kamer

Kimberli Kamer has an extensive work experience in the field of scientific research and development. Their most recent role is that of a Senior Scientist at Entrada Therapeutics, where they started in 2023. Prior to this position, they worked at Entrada Therapeutics as a Scientist II from 2019 to 2022, and as a Scientist from 2019 to 2021.

Before joining Entrada Therapeutics, Kimberli worked as a Postdoctoral Fellow at Massachusetts General Hospital from May 2018 to April 2019, conducting research under the guidance of Prof. Vamsi Mootha. Kimberli also completed their Ph.D. in Chemistry and Chemical Biology at Harvard University, where they worked from September 2011 to April 2018.

Kimberli's earlier experience includes working as a Student Researcher at the University of Wisconsin-Madison from 2008 to 2011, with Prof. Ronald Raines as their advisor. Additionally, they worked as a Student Researcher at the Endocrine Research Lab in 2008, under the guidance of Prof. Hershel Raff.

Kimberli Kamer completed their Bachelor of Science (B.S.) degree in Biomedical Engineering and Biochemistry at the University of Wisconsin-Madison from 2007 to 2011. Kimberli then pursued a PhD in Chemistry and Chemical Biology at Harvard University from 2011 to 2018.